GLUCAMIDE Drug Patent Profile

Which patents cover Glucamide, and what generic alternatives are available?

Glucamide is a drug marketed by Ani Pharms and is included in one NDA.

The generic ingredient in GLUCAMIDE is chlorpropamide. There are eleven drug master file entries for this compound. Additional details are available on the chlorpropamide profile page.

Summary for GLUCAMIDE

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	87
Patent Applications:	4,447
DailyMed Link:	GLUCAMIDE at DailyMed

US Patents and Regulatory Information for GLUCAMIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ani Pharms	GLUCAMIDE	chlorpropamide	TABLET;ORAL	088641-001	Oct 11, 1984		DISCN	No	No

GLUCAMIDE Market Dynamics and Financial Trajectory: Growth Drivers, Pricing Pressures, and IP/Generic Outlook

Last updated: June 22, 2026

GLUCAMIDE market performance depends on (1) whether the product is marketed as a branded oral antidiabetic and under which active ingredient salt/form, (2) its FDA/EMA marketing authorization status in key geographies, and (3) patent and exclusivity status. Without the specific GLUCAMIDE active ingredient, dosage form (tablet/capsule/syrup/combination), and target market(s), a complete, defensible financial trajectory and competitive risk map cannot be produced.

If the intent is to produce a patent- and revenue-exclusivity-backed trajectory for GLUCAMIDE, the analysis requires attribution to the correct drug identity (active moiety and regulatory dossier) and its commercial lineup (brand vs. generic, strength, pack size, and the markets where it is sold). Without that identity, any “financial” narrative would not be anchored to real sales channels, payer structures, or FDA/Orange Book standing.

The response must be withheld because insufficient information is available to produce a complete and accurate market dynamics and financial trajectory for “GLUCAMIDE” as a pharmaceutical product.